DJ Winston, ES Huang, MJ Miller, CH LIN, … - Annals of internal medicine, 1985 - Am Coll Physicians Restriction endonuclease analysis of purified viral DNA was used to study the
molecular epidemiologic characteristics of cytomegalovirus infection in 18
patients having bone marrow transplantation. Four patients who had had ... Cited by 61 - Related articles - All 3 versions
JP Grob, JE Grundy, HG Prentice, PD … - Lancet, 1987 - ncbi.nlm.nih.gov To study the importance of transferred immunity against cytomegalovirus (CMV) in
allogeneic, HLA-matched, T-cell-depleted bone-marrow transplantation, the
incidence, severity, and outcome of CMV infections were studied in 40 CMV- ... Cited by 69 - Related articles - All 4 versions
[CITATION] A randomized trial of intravenous hyperimmune globulin for the prevention of …
- ►hematologylibrary.org [PDF] W Miller, P Flynn, J McCullough, HH Balfour … - Blood, 1986 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 138 - Related articles - All 4 versions
EC Reed, RA Bowden, PS Dandliker, CA … - The Journal of infectious diseases, 1987 - jstor.org Cytomegalovirus frequently causes illness in immunosup- pressed patients,
including patients with AIDS and pa- tients undergoing organ allografting.
Cytomegalovirus pneumonia in marrow transplant recipients is a particu- ... Cited by 29 - Related articles - All 3 versions
[CITATION] Preliminary data of a controlled trial of intravenous hyperimmune globulin in the prevention …
JE Grundy, JD Shanley, PD Griffiths - Lancet(British edition), 1987 - cat.inist.fr Is cytomegalovirus interstitial pneumonitis in transplant recipients an
immunopathological condition? JE GRUNDY, JD SHANLEY, PD ... Cited by 162 - Related articles - All 4 versions
RA Bowden, M Sayers, CA Gleaves, M Banaji … - Transfusion, 1987 - interscience.wiley.com The authors report 2.5 years' experience with the use of cytomegalovirus
(CMV)-seronegative blood components for the prevention of primary CMV infection
after allogeneic marrow transplantation from seronegative marrow donors to ... Cited by 34 - Related articles - All 3 versions
P Wertheim, C Buurman, J Geelen, J Van der … - Lancet, 1983 - ncbi.nlm.nih.gov 1: Lancet. 1983 Apr 30;1(8331):980-1. Transmission of cytomegalovirus by
renal allograft demonstrated by restriction enzyme analysis. ... Cited by 18 - Related articles - All 2 versions
EC REED, PS DANDLIKER, JD MEYERS - Annals of internal medicine, 1986 - Am Coll Physicians Grant support: by a grant from the Burroughs Wellcome Company; by grants CA
18029 and CA 15704 from the National Institutes of Health; and in part by a
grant from the Poncin Scholarship Fund (Dr. Reed). Cited by 36 - Related articles - All 3 versions
